At a glance
ClinicalIndex Comparison RecordN/ACompleted· 589 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Real-world Study in Acute Leukemia: Epidemiology, Treatment Patterns and Outcomes for B-cell ALL and AML in Adult Patients From Latin America - LOYAL Study
In Brief
An observational study for Acute Myeloid Leukemia and Acute Lymphoid Leukemia. Completed, enrolled 589 participants across 14 sites in 4 countries.
Detailed Summary
The objective of the study is to describe the current epidemiology, treatment patterns, outcomes and healthcare resource use of adult patients diagnosed with relapsed/refractory (R/R) B-cell ALL and de novo AML in 4 Latin American countries.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Myeloid Leukemia, Acute Lymphoid Leukemia
CountriesArgentina, Brazil, Chile, Colombia
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartDec 2021
First PostedDec 2021
Primary CompletionNov 2022
TodayJul 2026
First PostedDec 21, 2021
Enrollment StartDec 10, 2021
Primary CompletionNov 15, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.5 years ago